PMC:7544934 / 4391-4971 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"140","span":{"begin":284,"end":288},"obj":"Gene"},{"id":"141","span":{"begin":63,"end":73},"obj":"Species"},{"id":"142","span":{"begin":273,"end":278},"obj":"Species"},{"id":"143","span":{"begin":571,"end":579},"obj":"Disease"}],"attributes":[{"id":"A140","pred":"tao:has_database_id","subj":"140","obj":"Gene:59272"},{"id":"A141","pred":"tao:has_database_id","subj":"141","obj":"Tax:2697049"},{"id":"A142","pred":"tao:has_database_id","subj":"142","obj":"Tax:9606"},{"id":"A143","pred":"tao:has_database_id","subj":"143","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"There is a very fast ongoing search for therapeutics acting on SARS-CoV-2 (Hussain, 2020). Depending on the activity, the therapies can be divided into majorly main categories: (1) Inhibiting the viral RNA synthesis and replication, (2) Deterring the virus from binding to human cell ACE2 receptors, (3) Reinstating the innate immunity, and (4) Blocking the host’s specific receptors or enzymes. Despite many experimental and computational studies currently exploring all of these categories, to date, there is no confirmed effective treatment specifically available for COVID-19."}

{"project":"LitCovid-sentences","denotations":[{"id":"T35","span":{"begin":0,"end":90},"obj":"Sentence"},{"id":"T36","span":{"begin":91,"end":395},"obj":"Sentence"},{"id":"T37","span":{"begin":396,"end":580},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"There is a very fast ongoing search for therapeutics acting on SARS-CoV-2 (Hussain, 2020). Depending on the activity, the therapies can be divided into majorly main categories: (1) Inhibiting the viral RNA synthesis and replication, (2) Deterring the virus from binding to human cell ACE2 receptors, (3) Reinstating the innate immunity, and (4) Blocking the host’s specific receptors or enzymes. Despite many experimental and computational studies currently exploring all of these categories, to date, there is no confirmed effective treatment specifically available for COVID-19."}